放射治疗在宫颈癌治疗中的应用及更新

doi:10.12114/j.issn.1007-9572.2022.0058

中国全科医学 ›› 2022, Vol. 25 ›› Issue (18): 2239-2243.DOI: 10.12114/j.issn.1007-9572.2022.0058

所属专题：肿瘤最新文章合集

• 论著·宫颈癌专题研究 • 上一篇下一篇

放射治疗在宫颈癌治疗中的应用及更新

林雨璇, 孔为民^*(), 王元景, 李凤霜

100006　北京市，首都医科大学附属北京妇产医院妇科肿瘤科

收稿日期:2021-12-12 修回日期:2022-03-30 出版日期:2022-06-20 发布日期:2022-04-07
通讯作者: 孔为民
林雨璇，孔为民，王元景，等.放射治疗在宫颈癌治疗中的应用及更新[J].中国全科医学，2022，25（18）：2239-2243. [www.chinagp.net]
作者贡献：林雨璇负责论文主要部分的撰写，完成相关文献资料的收集和分析及论文初稿的写作；孔为民负责论文的构思布局，指导论文写作、审查及编辑，进行最终版本的修订，并对论文负责；王元景、李凤霜负责文献资料的分析、整理。

Application and Update of Radiotherapy in the Treatment of Cervical Cancer

Yuxuan LIN, Weimin KONG^*(), Yuanjing WANG, Fengshuang LI

Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 10006, China

Received:2021-12-12 Revised:2022-03-30 Published:2022-06-20 Online:2022-04-07
Contact: Weimin KONG
About author:
LIN Y X, KONG W M, WANG Y J, et al. Application and update of radiotherapy in the treatment of cervical cancer[J]. Chinese General Practice, 2022, 25 (18) : 2239-2243.

分享到

摘要/Abstract

摘要： 放射治疗作为宫颈癌三大治疗方法之一，在宫颈癌治疗中占有重要地位。近年来，三维体外照射及三维腔内照射等新技术开始广泛应用于宫颈癌治疗，这些新技术在提高肿瘤照射剂量的同时还减少了周围正常组织的受量。此外，对于以影像学指标指导个体化放射治疗、质子治疗的探索等研究也在不断进行中。本文对宫颈癌放射治疗的基本知识、放射治疗在宫颈癌治疗中的应用进展进行阐述，总结新技术的适用情况，并提出新技术使用中需注意的问题，以期指导临床应用。

关键词: 宫颈肿瘤, 放射疗法, 放射疗法，影像引导, 分次剂量，放射疗法

Abstract:

As one of the three major treatments for cervical cancer, radiotherapy plays an important role in treating cervical cancer. In recent years, new technologies such as three-dimensional external beam radiotherapy and image-based brachytherapy have been widely used in the treatment of cervical cancer, which can increase the dose of tumor radiation while reducing the dose radiating surrounding normal tissues. In addition, the researches on the use of individualized radiotherapy guided by imaging indicators and proton therapy are also in progress. This paper presents the basic knowledge of radiotherapy for cervical cancer and the application of radiotherapy in the treatment of cervical cancer, summarizes the application of new technologies, and proposes issues that need to be emphasized in the use of new technologies, in order to guide clinical application.

Key words: Uterine cervical neoplasms, Radiotherapy, Radiotherapy, image-guided, Dose fractionation, radiation

林雨璇,孔为民,王元景,等. 放射治疗在宫颈癌治疗中的应用及更新[J]. 中国全科医学, 2022, 25(18): 2239-2243. DOI: 10.12114/j.issn.1007-9572.2022.0058.
Yuxuan LIN,Weimin KONG,Yuanjing WANG, et al. Application and Update of Radiotherapy in the Treatment of Cervical Cancer[J]. Chinese General Practice, 2022, 25(18): 2239-2243. DOI: 10.12114/j.issn.1007-9572.2022.0058.

图/表 1

参考文献 28

[1]	孙建衡，盛修贵，白萍. 妇科肿瘤学[M]. 2版. 北京：北京大学医学出版社，2019：236.
[2]	National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Cervical cancer [EB/OL]. [2021-02-19].
[3]	LANDONI F, MANEO A, COLOMBO A，et al. Randomised study of radical surgery versus radiotherapy for stageⅠb-Ⅱa cervical cancer[J]. Lancet，1997，350(9077):535-540. DOI：10.1016/S0140-6736(97)02250-2.
[4]	SEDLIS A, BUNDY B N, ROTMAN M Z，et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stageⅠB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy：a Gynecologic Oncology Group Study[J]. Gynecol Oncol，1999，73(2):177-183. DOI：10.1006/gyno.1999.5387.
[5]	DATTA N R, STUTZ E, LIU M，et al. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer：a systematic review and meta-analysis[J]. Gynecol Oncol，2017，145(2):374-385. DOI：10.1016/j.ygyno.2017.01.033.
[6]	CHINO J, ANNUNZIATA C M, BERIWAL S，et al. Radiation therapy for cervical cancer：executive summary of an ASTRO clinical practice guideline[J]. Pract Radiat Oncol，2020，10(4):220-234. DOI：10.1016/j.prro.2020.04.002.
[7]	宋慧胜，陈龙华，冯正富，等. 宫颈癌三维适形放射治疗与常规放射治疗临床观察[J]. 西部医学，2011，23(5):838-841. DOI：10.3969/j.issn.1672-3511.2011.05.014.
[8]	郭智，臧志芳，麻富卯，等. 三维适形放疗治疗复发子宫颈癌的剂量学研究[J]. 肿瘤研究与临床，2008，20(6):387-389. DOI：10.3760/cma.j.issn.1006-9801.2008.06.010.
[9]	LUO H C, LIN G S, LIAO S G，et al. Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria （NCCN VS RTOG）[J]. Br J Radiol，2018，91(1081):20170398. DOI：10.1259/bjr.20170398.
[10]	NAIK A, GURJAR O P, GUPTA K L，et al. Comparison of dosimetric parameters and acute toxicity of intensity-modulated and three-dimensional radiotherapy in patients with cervix carcinoma：a randomized prospective study[J]. Cancer Radiother，2016，20(5):370-376. DOI：10.1016/j.canrad.2016.05.011.
[11]	KLOPP A H, YEUNG A R, DESHMUKH S，et al. Patient-reported toxicity during pelvic intensity-modulated radiation therapy：NRG oncology-RTOG 1203[J]. J Clin Oncol，2018，36(24):2538-2544. DOI：10.1200/JCO.2017.77.4273.
[12]	CHANG Y, YANG Z Y, LI G L，et al. Correlations between radiation dose in bone marrow and hematological toxicity in patients with cervical cancer：a comparison of 3DCRT，IMRT，and RapidARC[J]. Int J Gynecol Cancer，2016，26(4):770-776. DOI：10.1097/IGC.0000000000000660.
[13]	LIN A J, KIDD E, DEHDASHTI F，et al. Intensity modulated radiation therapy and image-guided adapted brachytherapy for cervix cancer[J]. Int J Radiat Oncol Biol Phys，2019，103(5):1088-1097. DOI：10.1016/j.ijrobp.2018.11.012.
[14]	OSBORNE E M, KLOPP A H, JHINGRAN A，et al. Impact of treatment year on survival and adverse effects in patients with cervical cancer and paraortic lymph node metastases treated with definitive extended-field radiation therapy[J]. Pract Radiat Oncol，2017，7(3):e165-173. DOI：10.1016/j.prro.2016.09.003.
[15]	WAKATSUKI M, KATO S, OHNO T，et al. Multi-institutional observational study of prophylactic extended-field concurrent chemoradiation therapy using weekly cisplatin for patients with pelvic node-positive cervical cancer in east and Southeast Asia[J]. Int J Radiat Oncol Biol Phys，2019，105(1):183-189. DOI：10.1016/j.ijrobp.2019.04.039.
[16]	YU C, ZHU W, JI Y，et al. A comparative study of intensity-modulated radiotherapy and standard radiation field with concurrent chemotherapy for local advanced cervical cancer[J]. Eur J Gynaecol Oncol，2015，36(3):278-282.
[17]	MARJANOVIC D, PLESINAC KARAPANDZIC V, STOJANOVIC RUNDIC S，et al. Implementation of intensity-modulated radiotherapy and comparison with three-dimensional conformal radiotherapy in the postoperative treatment of cervical cancer[J]. J BUON，2019，24(5):2028-2034.
[18]	GUO M F, HUANG E L, LIU X F，et al. Volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy in radical irradiation for cervical cancer without lymphadenectasis：dosimetric and clinical results[J]. Oncol Res Treat，2018，41(3):105-109. DOI：10.1159/000484608.
[19]	WALI L, HELAL A, DARWESH R，et al. A dosimetric comparison of Volumetric Modulated Arc Therapy （VMAT） and High Dose Rate （HDR） brachytherapy in localized cervical cancer radiotherapy[J]. J Xray Sci Technol，2019，27(3):473-483. DOI：10.3233/XST-180468.
[20]	郭明芳，柳先锋，刘俐，等. 螺旋断层放疗在早期年轻宫颈癌患者保卵巢根治术后放疗中的剂量学研究[J]. 重庆医科大学学报，2019，44(1):39-42. DOI：10.13406/j.cnki.cyxb.001873.
[21]	DE BOER P, VAN DE SCHOOT A J A J, WESTERVELD H，et al. Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy：a comparison of benefits[J]. Al，2018，194(3):255-263. DOI：10.1007/s00066-017-1224-8.
[22]	MAYADEV J, VISWANATHAN A, LIU Y，et al. American Brachytherapy Task Group Report：a pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer[J]. Brachytherapy，2017，16(1):22-43. DOI：10.1016/j.brachy.2016.03.008.
[23]	FIELDS E C, HAZELL S, MORCOS M，et al. Image-guided gynecologic brachytherapy for cervical cancer[J]. Semin Radiat Oncol，2020，30(1):16-28. DOI：10.1016/j.semradonc.2019.08.010.
[24]	DIMOPOULOS J C A, PETROW P, TANDERUP K，et al. Recommendations from Gynaecological （GYN） GEC-ESTRO Working Group （IV）：basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy[J]. Radiother Oncol，2012，103(1):113-122. DOI：10.1016/j.radonc.2011.12.024.
[25]	BATUMALAI V, BURKE S, ROACH D，et al. Impact of dosimetric differences between CT and MRI derived target volumes for external beam cervical cancer radiotherapy[J]. Br J Radiol，2020，93(1114):20190564. DOI：10.1259/bjr.20190564.
[26]	CARESIA-ARÓZTEGUI A P, DELGADO-BOLTON R C, ALVAREZ-RUIZ S，et al. 18F-FDG PET/CT in locally advanced cervical cancer：a review[J]. Rev Esp Med Nucl Imagen Mol （Engl Ed），2019，38(1):59-68. DOI：10.1016/j.remn.2018.08.004.
[27]	KHIEWVAN B, TORIGIAN D A, EMAMZADEHFARD S，et al. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer[J]. Hell J Nucl Med，2016，19(3):254-268. DOI：10.1967/s002449910409.
[28]	HOLSCHNEIDER C H, PETEREIT D G, CHU C，et al. Brachytherapy：a critical component of primary radiation therapy for cervical cancer：from the Society of Gynecologic Oncology （SGO） and the American Brachytherapy Society （ABS）[J]. Brachytherapy，2019，18(2):123-132. DOI：10.1016/j.brachy.2018.11.009.

LVSI	DSI	TS
+	>2/3	任意大小
+	1/3~2/3	≥2 cm
+	<1/3	≥5 cm
-	>1/3	≥4 cm

LVSI	DSI	TS
+	>2/3	任意大小
+	1/3~2/3	≥2 cm
+	<1/3	≥5 cm
-	>1/3	≥4 cm

放射治疗在宫颈癌治疗中的应用及更新

Application and Update of Radiotherapy in the Treatment of Cervical Cancer

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 28

相关文章 15

编辑推荐

Metrics

留言

[1]	洪子强, 金大成, 白向豆, 崔百强, 苟云久. 多原发肺癌诊断与治疗的最新研究进展[J]. 中国全科医学, 2022, 25(27): 3435-3442.
[2]	夏依旦·罗合曼江, 杜蓉. 不同级别宫颈病变与人乳头瘤病毒感染及阴道微环境的关系研究[J]. 中国全科医学, 2022, 25(23): 2881-2884.
[3]	刘玉, 韦艳, 杨萍. 2019年和2020年新疆石河子城区宫颈癌筛查结果对比研究[J]. 中国全科医学, 2022, 25(18): 2223-2230.
[4]	刘双环, 李斌. 宫颈癌根治性手术的术式精准选择与实施[J]. 中国全科医学, 2022, 25(18): 2231-2234.
[5]	张清泉, 王世军. 宫颈癌淋巴结的评估与手术策略探讨[J]. 中国全科医学, 2022, 25(18): 2235-2238.
[6]	王瑾瑶, 张年萍, 白志强, 王震坤. 1993—2017年中国宫颈癌发病率和死亡率长期趋势的年龄-时期-队列模型分析[J]. 中国全科医学, 2022, 25(13): 1564-1568.
[7]	徐碧霞, 林小丹, 姚卫光. 2015—2019年广东省户籍妇女宫颈癌患病率时间和空间分布特征分析[J]. 中国全科医学, 2022, 25(06): 735-741.
[8]	张军. 宫颈癌治疗的现状及问题：从临床指南到真实世界研究[J]. 中国全科医学, 2022, 25(03): 259-263.
[9]	李婷婷，王翠峰. 高危型人乳头瘤病毒联合宫颈液基薄层细胞学检测在宫颈上皮内瘤变筛查中的应用价值[J]. 中国全科医学, 2021, 24(9): 1106-1110.
[10]	韦艳，白瑞，阮阳阳，孙倩玉，刁博文，杨萍. 新疆维吾尔自治区石河子市城区18 378例子宫颈癌筛查人群的hrHPV感染状况研究[J]. 中国全科医学, 2021, 24(29): 3763-3768.
[11]	中国医师协会全科医师分会，北京妇产学会社区与基层分会. 子宫颈癌筛查结果异常人群社区管理专家建议[J]. 中国全科医学, 2021, 24(17): 2117-2121.
[12]	张涛红，张萌，高丽，薛艳，王丽莎，安瑞芳. 经手术治疗宫颈癌患者的临床特征研究[J]. 中国全科医学, 2020, 23(25): 3207-3211.
[13]	黄静，杨湘红，刘爱，周雯娟. 农村地区妇女“两癌筛查”项目实施中的问题与对策[J]. 中国全科医学, 2020, 23(13): 1680-1686.
[14]	余杨，付艳丽，孙翔. 高危型人乳头瘤病毒载量对不同宫颈病变调节性T淋巴细胞表达的影响研究[J]. 中国全科医学, 2019, 22(5): 538-543.
[15]	鲁亮，刘爱华，张汉群，曹辉，李勇，冯志宇，李杭. 培美曲塞联合长春瑞滨治疗一线化疗失败的复发转移性宫颈癌的疗效研究[J]. 中国全科医学, 2019, 22(30): 3679-3682.